Masoud Maher, President and CEO of MaxCyte, Inc. ($MXCT), made one open market purchase of company shares in the last year, totaling just over $100,000, with the most recent on August 13, 2025. This ranks him 2,126th among nearly 5,000 insiders for purchase value, well below the average of $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | MAXCYTE, INC. | $MXCT | Masoud Maher | President and CEO | A | Common Stock | 300000 | $0.00 | 475,000.0000 | 106,427,854 | 171.43% | 0.28% |
| March 27, 2026 | MAXCYTE, INC. | $MXCT | Masoud Maher | President and CEO | A | Employee Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 106,427,854 | 9999.99% | 0.56% |
| Aug. 13, 2025 | MAXCYTE, INC. | $MXCT | Masoud Maher | President and CEO | P | Common Stock | 75000 | $1.37 | 175,000.0000 | 106,403,540 | 75.00% | 0.07% |
| March 14, 2025 | MAXCYTE, INC. | $MXCT | Masoud Maher | President and CEO | A | Employee Stock Option (right to buy) | 347500 | $0.00 | 347,500.0000 | 104,849,222 | 9999.99% | 0.33% |
| June 10, 2024 | MAXCYTE, INC. | $MXCT | Masoud Maher | President and CEO | P | Common Stock | 70443 | $4.90 | 100,000.0000 | 104,089,758 | 238.33% | 0.07% |
| June 7, 2024 | MAXCYTE, INC. | $MXCT | Masoud Maher | President and CEO | P | Common Stock | 29557 | $4.87 | 29,557.0000 | 104,089,758 | 9999.99% | 0.03% |
| Jan. 3, 2024 | MAXCYTE, INC. | $MXCT | Masoud Maher | President and CEO | A | Employee Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 103,268,502 | 9999.99% | 0.39% |
| March 20, 2023 | MAXCYTE, INC. | $MXCT | Masoud Maher | EVP and General Counsel | A | Employee Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 101,702,664 | 9999.99% | 0.12% |